TNF and sarcoidosis: Because of the central role of tumor necrosis factor alpha (TNF-α) in the pathophysiology of the granulomatous inflammation, TNF-α antagonists as infliximab have become a promising and increasingly used treatment in sarcoidosis and NS [1, 12, 56].